CFO
Knight Therapeutics Inc.
Equibles does not estimate personal net worth.
Arvind Uchina is recorded as CFO at Knight Therapeutics Inc.. Arvind Uchina has spoken on 1 earnings call across 1 company, most recently for Knight Therapeutics Inc. on November 5, 2026. Knight Therapeutics Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“When speaking of our financial results, I will refer to certain non-IRS measures, including adjusted revenues, adjusted gross margin, adjusted EBITDA, and adjusted EBITDA per share, as well as constant currency results.”
Knight Therapeutics Inc.
CFO
Transcript header (unverified)
Knight Therapeutics Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Knight Therapeutics' Third Quarter 2026 Results Conference Call
Knight Therapeutics Inc.
